Theriva Biologics, Inc. Operating Lease, Liability, Noncurrent
Theriva Biologics, Inc. (TOVX) had Operating Lease, Liability, Noncurrent of $1.37 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability, Noncurrent $1.37M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $1.52M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $352.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $433.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $1.37M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.52M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $352.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $433.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $584.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $732.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $873.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.03M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.16M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.30M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.44M 10-K · filed 2025-03-06 |
| 2023-09-30 | $1.55M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.68M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.19M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.24M 10-K · filed 2023-03-30 |
| 2022-06-30 | $1.30M 10-K · filed 2023-03-30 |
| 2022-03-31 | $1.35M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.40M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.40M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.43M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $108.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $186.00K 10-K · filed 2022-03-16 |
| 2020-09-30 | $261.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $334.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $405.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $473.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $539.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $601.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $662.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |